Table 1

Patient demographics

S-25(OH)D concentration
All patientsDeficient (≤8 ng/ml)Low normal (>8 and ≤15 ng/ml)Normal (>15 ng/ml)
Results are expressed as mean (SD).
*Significantly different from the normal group (p>0.05, one way ANOVA).
S-25(OH)D), serum 25-hydroxyvitamin D; pre women, premenopausal women; post women, postmenopausal women; CD, Crohn’s disease; MT, mesenteric thrombosis; Surg, complications related to surgery; BMI, body mass index; PO, per oral 400 IU/day; >PO, per oral >400 IU/day; IM, intramuscularly 100 000 IU/month.
No of patients42161016
Sex (pre women/post women/men) (n)15/9/189/3/48/0/26/6/4
Diagnosis (CD/MT/Surg.) (n)35/3/414/1/17/2/114/0/2
Age (y) 50.3 (12.3) 44.1 (12.2)* 52.2 (9.9) 55.2 (11.7)
Weight (kg) 62.8 (13.2) 60.6 (15.3) 71.1 (13.8) 59.8 (8.1)
Height (cm)168.8 (9.3)166.1 (8.0)172.9 (11.0)168.9 (9.0)
BMI (kg/m2) 22.0 (3.9) 21.8 (4.4) 23.7 (3.6) 21.0 (3.4)
Renal creatinine clearance (ml/min) 79.4 (30.7) 77.9 (37.2) 93.8 (30.2) 71.3 (20.9)
Small bowel length (cm)199.1 (70.6)196.1 (73.6)189.7 (92.4)208.0 (54.1)
Remaining colon (%) 37.8 (40.8) 34.4 (42.7) 50.0 (40.8) 29.7 (39.0)
Faecal fat excretion (g/day) 46.9 (38.1) 43.2 (21.5) 47.9 (47.3) 50.0 (46.4)
Vitamin D suppl (none/PO/>PO/IM) (n)11/14/10/77/5/2/22/4/3/12/5/5/4
Calcium suppl (0/500/1000/>2000 (mg/day)) (n)16/7/17/26/2/5/37/2/0/13/3/5/5